Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis

Background. Interstitial lung disease (ILD) is the most common complication of systemic sclerosis (SSc) with treatment ineffective. Objective: The aim of this meta-analysis was to provide an estimate of the safety and efficacy profile of Mycophenolate Mofetil (MMF) or sodium (MMS) in SSc-ILD patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Tzouvelekis, Argyris, Galanopoulos, Nikolaos, Bouros, Evangelos, Kolios, George, Zacharis, George, Ntolios, Paschalis, Koulelidis, Andreas, Oikonomou, Anastasia, Bouros, Demosthenes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357562/
https://www.ncbi.nlm.nih.gov/pubmed/22655194
http://dx.doi.org/10.1155/2012/143637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357562/
https://www.ncbi.nlm.nih.gov/pubmed/22655194
http://dx.doi.org/10.1155/2012/143637

Ejemplares similares